NCT03090776View on ClinicalTrials.gov

Prevention of Post Mastectomy With Intraoperative Ketamine

EARLY_PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

July 1, 2017

Primary Completion Date

October 16, 2025

Study Completion Date

December 1, 2025

Conditions
Pain, PostoperativePost-Mastectomy Chronic Pain Syndrome
Interventions
DRUG

Ketamine

low dose bolus and infusion ketamine, administered under general anesthesia

OTHER

Placebo saline

bolus and infusion saline, administered under general anesthesia

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Institute of General Medical Sciences (NIGMS)

NIH

lead

Brigham and Women's Hospital

OTHER